Mark Eisner
CIK 1834161 · EVP and Chief Medical Officer · last filed 2026-02-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.34M
Companies
3
Total Filings
25
Lifetime Open-Market Net
-$720.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIR | EVP and Chief Medical Officer | 155,913 | $8.61 | $1.34M | -$106.3K | 5 | 2026-02-26 |
| ZURA | Director | — | $3.70 | — | $0 | 1 | 2026-02-24 |
| KYNTRA BIO, INC. (FGEN) Delisted | EVP, Chief Medical Officer | 159,917 | $9.75 | $1.56M | -$614.3K | 19 | 2023-09-08 |
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-02-16 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +60,000 | $0 | EDGAR |
| 2022-01-05 | KYNTRA BIO, INC. (FGEN) Delisted | Tax (F) | −7,043 | -$104.4K | EDGAR |
| 2021-12-03 | KYNTRA BIO, INC. (FGEN) Delisted | Tax (F) | −4,338 | -$54.9K | EDGAR |
| 2021-10-06 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +74,520 | $0 | EDGAR |
| 2020-12-03 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.